Compare LRN & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LRN | TFX |
|---|---|---|
| Founded | 2000 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3B | 5.4B |
| IPO Year | 2007 | N/A |
| Metric | LRN | TFX |
|---|---|---|
| Price | $67.59 | $108.94 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 10 |
| Target Price | $106.75 | ★ $139.88 |
| AVG Volume (30 Days) | ★ 1.2M | 732.0K |
| Earning Date | 01-27-2026 | 02-26-2026 |
| Dividend Yield | N/A | ★ 1.24% |
| EPS Growth | ★ 15.30 | N/A |
| EPS | ★ 6.34 | N/A |
| Revenue | $2,475,117,000.00 | ★ $3,189,988,000.00 |
| Revenue This Year | $5.60 | $9.90 |
| Revenue Next Year | $4.69 | $10.51 |
| P/E Ratio | $10.91 | ★ N/A |
| Revenue Growth | ★ 17.25 | 5.42 |
| 52 Week Low | $60.62 | $102.58 |
| 52 Week High | $171.17 | $185.94 |
| Indicator | LRN | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 49.08 | 31.34 |
| Support Level | $66.67 | $108.39 |
| Resistance Level | $69.55 | $127.49 |
| Average True Range (ATR) | 1.86 | 3.05 |
| MACD | 1.11 | -1.58 |
| Stochastic Oscillator | 67.13 | 4.14 |
Stride Inc is an American online educational company. It offers alternative programs to traditional on-campus schooling. It also operates state-funded virtual charter schools around the United States. The educational programs for K-12 students are usually monitored by parents and provide virtual classroom environments where teachers meet with students online, by phone, or in-person. The company's contractual agreements with various school districts to offer its curriculum programs provide a majority of the company's revenue. The company lines of business are Managed Public School Programs, Institutional and Private Pay Schools and Other.
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.